BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32611898)

  • 1. The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence.
    Almeida JP; Tabasinejad R; Kalyvas A; Takami H; Mohan N; O'Halloran PJ; Sanchez MM; Velasquez C; Zadeh G; Gentili F
    Neurol India; 2020; 68(Supplement):S92-S100. PubMed ID: 32611898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas.
    Gerges MM; Rumalla K; Godil SS; Younus I; Elshamy W; Dobri GA; Kacker A; Tabaee A; Anand VK; Schwartz TH
    J Neurosurg; 2020 Jan; 134(2):535-546. PubMed ID: 32005016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned recurrence-free survival following gross-total resection of nonfunctioning pituitary adenoma: a single-surgeon, single-center retrospective study.
    McClure JJ; Chatrath A; Robison TR; Jane JA
    J Neurosurg; 2024 Jun; 140(6):1614-1619. PubMed ID: 38064693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results.
    Asha MJ; Takami H; Velasquez C; Oswari S; Almeida JP; Zadeh G; Gentili F
    J Neurosurg; 2019 Oct; 133(5):1360-1370. PubMed ID: 31604330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.
    Lee JYK; Cho SS; Zeh R; Pierce JT; Martinez-Lage M; Adappa ND; Palmer JN; Newman JG; Learned KO; White C; Kharlip J; Snyder P; Low PS; Singhal S; Grady MS
    J Neurosurg; 2018 Aug; 129(2):390-403. PubMed ID: 28841122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes.
    Buliman A; Tataranu LG; Ciubotaru V; Cazac TL; Dumitrache C
    J Med Life; 2016; 9(2):187-92. PubMed ID: 27453753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated risk of recurrence and retreatment for silent pituitary adenomas.
    Gupta S; Hoffman SE; Mehta NH; Hauser B; Altshuler M; Bernstock JD; Smith TR; Arnaout O; Laws ER
    Pituitary; 2024 Apr; 27(2):204-212. PubMed ID: 38345720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and therapeutic outcomes of pediatric pituitary adenomas: a single pituitary center experience.
    Kilci F; Jones JH; Çaklılı M; Ceylan S; Çizmecioğlu-Jones FM
    Endocrine; 2024 Jan; 83(1):160-170. PubMed ID: 37779166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and surgical outcomes of very large and giant pituitary adenomas: 80 cases in a cohort study of 306 patients with pituitary adenomas.
    Pascual-Corrales E; Acitores Cancela A; Baonza G; Madrid Egusquiza I; Rodríguez Berrocal V; Araujo-Castro M
    Acta Neurochir (Wien); 2024 May; 166(1):225. PubMed ID: 38772927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis.
    Staartjes VE; Togni-Pogliorini A; Stumpo V; Serra C; Regli L
    Pituitary; 2021 Aug; 24(4):644-656. PubMed ID: 33945115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and surgical nuances in management of giant pituitary adenomas: a review of 108 cases in the endoscopic era.
    Makarenko S; Alzahrani I; Karsy M; Deopujari C; Couldwell WT
    J Neurosurg; 2022 Sep; 137(3):635-646. PubMed ID: 35061979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Resection and Surgical Experience on Survival in Patients with Craniopharyngiomas: Endoscopic Transsphenoidal Surgery in Series of 31 Cases.
    Erkan B; Barut O; Akpinar E; Cil MS; Demir S; Kilic Y; Tanriverdi O; Hatipoglu ES; Gunaldi O
    Turk Neurosurg; 2024; 34(2):331-342. PubMed ID: 38497187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients.
    Ottenhausen M; Conrad J; Wolters LM; Ringel F
    Neurosurg Rev; 2023 May; 46(1):128. PubMed ID: 37249700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data.
    Youngerman BE; Banu MA; Gerges MM; Odigie E; Tabaee A; Kacker A; Anand VK; Schwartz TH
    J Neurosurg; 2020 Jul; 135(1):113-125. PubMed ID: 32707549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.
    Cho SS; Jeon J; Buch L; Nag S; Nasrallah M; Low PS; Grady MS; Singhal S; Lee JYK
    J Neurosurg; 2018 Dec; 131(6):1974-1984. PubMed ID: 30554181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
    Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
    J Neurosurg; 2021 May; 135(6):1706-1713. PubMed ID: 33962375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-radiological parameters, biochemical and molecular alterations predicting remission and recurrence after surgical treatment of corticotroph adenomas - Cushing's disease.
    Sadhwani N; Bora SK; Deepa S; Katiyar V; Raheja A; Garg A; Suri V; Tandon N; Sharma MC; Khadgawat R; Suri A
    World Neurosurg; 2024 May; ():. PubMed ID: 38734175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Surgical Outcomes of Endoscopic Endonasal Approach for Giant Pituitary Adenomas: Analysis of Predictive Factors.
    Eguiluz-Melendez A; Sangrador-Deitos MV; Calderón-Yrigoyen PJ; Rodríguez-Hernández AL; Guinto-Nishimura YG; Alcazar-Felix JR; Caballero-Delgado S; Portocarrero-Ortiz AL; Valencia-Ramos C; Gómez-Amador LJ
    World Neurosurg; 2024 Apr; 184():e659-e673. PubMed ID: 38342172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients].
    Trukhina DA; Przhiyalkovskaya EG; Belaya ZE; Grigoriev AY; Azizyan VN; Mamedova EO; Rozhinskaya LY; Lapshina AM; Pigarova EA; Dzeranova LK; Platonova NM; Troshina EA; Melnichenko GA
    Probl Endokrinol (Mosk); 2023 Sep; 70(2):23-36. PubMed ID: 38796758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Limiting Complete Resection in the Subarachnoid Space in Endoscopic Surgery for Giant Pituitary Adenoma.
    Yang JY; Byun YH; Kim MS; Kim JH; Park CK; Kim YH; Kang H
    World Neurosurg; 2024 Jan; 181():e222-e233. PubMed ID: 37821027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.